The aseptic fill finish manufacturing market is witnessing growth opportunities driven by the rising demand for biologics, vaccines, and sterile injectables. Outsourcing to CMOs accelerates growth by ...

Earnings call Skye Bioscience reported durable, additive weight loss from its nimacimab and semaglutide combination, with no neuropsychiatric safety signals and clear plans to optimize dosing in ...